XMT 1001: Clinical Trials

1 trial of XMT 1001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow XMT 1001: new trials by email Literature Review of XMT 1001 trials Research Report on XMT 1001

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
XMT-1001 - Small Cell Lung Cancer, Non-small Cell Lung Cancer
Phase 1CompletedMersana Therapeutics302011-03-012018-01-31

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

Mersana Therapeutics (1)

Countries

United States (1)

Top investigators

Allen Lee Cohn, MD (1)  ·  David A. Smith, MD (1)  ·  Donald A. Richards, MD (1)  ·  Edward Sausville, MD (1)  ·  Fadi Braiteh, MD (1)  ·  Glen J Weiss, MD (1)  ·  Hillary H. Wu, MD (1)  ·  John R. Caton, MD (1)  ·  Lawrence Garbo, MD (1)  ·  Paul R. Conkling, MD (1)  ·  Stephen Anthony, MD (1)  ·  William J Edenfield, MD (1)